Skip to main content
. 2013 Aug 10;13:382. doi: 10.1186/1471-2407-13-382

Figure 3.

Figure 3

Pazopanib displays antiangiogenic activity in a CDDP-refractory model of testicular GCT. A) Percentage CD31-stained area in a viable tumor area and B) number of vessels in a viable tumor area were quantified using Volocity software. Means and SDs of six sections of each tumor were determined as the positive CD31-stained area relative to the control group. *, p < 0.05 (two-tail Mann–Whitney U test).